BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24457015)

  • 1. Pancreatic ductal adenocarcinoma: prevalence and diagnostic value of dark choledochal ring sign on T2-weighted MRI.
    Cha DI; Kim YK; Choi SY; Lim SH; Choi D; Lee WJ
    Clin Radiol; 2014 Apr; 69(4):416-23. PubMed ID: 24457015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK; Kim CS; Han YM; Lee YH
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value?
    Guo L; Liang C; Yu T; Wang G; Li N; Sun H; Gao F; Liu C
    Clin Radiol; 2012 Apr; 67(4):319-28. PubMed ID: 22099524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
    Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
    Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.
    Park MJ; Kim YK; Lim S; Rhim H; Lee WJ
    Radiology; 2014 Mar; 270(3):768-76. PubMed ID: 24475800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
    Kim YK; Lee YH; Kim CS; Lee MW
    Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal characteristic and enhancement patterns of pancreatic adenocarcinoma: evaluation with dynamic gadolinium enhanced MRI.
    Chandarana H; Babb J; Macari M
    Clin Radiol; 2007 Sep; 62(9):876-83. PubMed ID: 17662736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.
    Wu LM; Chen XX; Xu JR; Zhang XF; Suo ST; Yao QY; Fan Y; Hu J
    Acad Radiol; 2013 Aug; 20(8):939-46. PubMed ID: 23746384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic workup of primary sclerosing cholangitis: the benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography.
    Nolz R; Asenbaum U; Schoder M; Wibmer A; Einspieler H; Prusa AM; Peck-Radosavljevic M; Ba-Ssalamah A
    Clin Radiol; 2014 May; 69(5):499-508. PubMed ID: 24630133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study.
    Wu LM; Chen J; Hu J; Gu HY; Xu JR; Hua J
    Acta Radiol; 2014 Feb; 55(1):24-31. PubMed ID: 23878358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ; Kim YK; Lee MW; Lee WJ; Kim YS; Kim SH; Choi D; Rhim H
    Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
    Pilleul F; Rochette A; Partensky C; Scoazec JY; Bernard P; Valette PJ
    J Magn Reson Imaging; 2005 Mar; 21(3):237-44. PubMed ID: 15723374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.